Crossprotection induced by virus-like particles containing influenza dual-hemagglutinin and M2 ectodomain

被引:0
|
作者
Mao, Jie [1 ]
Eom, Gi-Deok [1 ]
Yoon, Keon-Woong [1 ]
Kim, Min-Ju [1 ]
Chu, Ki-Back [2 ]
Kang, Hae-Ji [3 ]
Quan, Fu-Shi [2 ,4 ]
机构
[1] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul 02447, South Korea
[2] Kyung Hee Univ, Biomed Sci Inst, Core Res Inst CRI, Med Res Ctr Bioreact React Oxygen Species, Seoul 02447, South Korea
[3] Georgia State Univ, Inst Biomed Sci, Ctr Translat Antiviral Res, Atlanta, GA 30303 USA
[4] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
hemagglutinin; influenza virus; M2e5x; universal vaccine; virus-like particles; CROSS-PROTECTION; VACCINE; MICE; H1N1; INFECTION; IMMUNITY; SUBTYPES;
D O I
10.2217/nnm-2023-0353
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: To develop an effective universal vaccine against antigenically different influenza viruses. Materials & methods: We generated influenza virus-like particles (VLPs) expressing the H1 and H3 antigens with or without M2e5x. VLP-induced immune responses and crossprotection against H1N1, H3N2 or H5N1 viruses were assessed to evaluate their protective efficacy. Results: H1H3M2e5x immunization elicited higher crossreactive IgG antibodies than H1H3 VLPs. Upon challenge, both VLPs enhanced lung IgG, IgA and germinal center B-cell responses compared with control. While these VLPs conferred protection, H1H3M2e5x showed greater lung viral load reduction than H1H3 VLPs with minimal body weight loss. Conclusion: Utilizing VLPs containing dual-hemagglutinin, along with M2e5x, can be a vaccination strategy for inducing crossprotection against influenza A viruses. [GRAPHICS] .
引用
收藏
页码:741 / 754
页数:14
相关论文
共 50 条
  • [21] Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles
    Chen, Benjamin J.
    Leser, George P.
    Morita, Eiji
    Lamb, Robert A.
    JOURNAL OF VIROLOGY, 2007, 81 (13) : 7111 - 7123
  • [22] Protection induced by early stage vaccination with pandemic influenza virus-like particles
    Lee, Gi-Ja
    Quan, Fu-Shi
    VACCINE, 2016, 34 (33) : 3764 - 3772
  • [23] Universal protection efficacy against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle vaccination in young and older adult mice
    Kim, Ki-Hye
    Li, Zhuo
    Bhatnagar, Noopur
    Subbiah, Jeeva
    Park, Bo Ryoung
    Shin, Chong Hyun
    Kang, Sang-Moo
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [24] Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2
    Zak, Andrew J.
    Hill, Brett D.
    Rizvi, Syed M.
    Smith, Mason R.
    Yang, Madeleine
    Wen, Fei
    ACS SYNTHETIC BIOLOGY, 2019, 8 (10): : 2303 - 2314
  • [25] Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity
    Kim, Min-Chul
    Lee, Yu-Na
    Hwang, Hye Suk
    Lee, Young-Tae
    Ko, Eun-Ju
    Jung, Yu-Jin
    Cho, Min Kyoung
    Kim, Yu-Jin
    Lee, Jong Seok
    Ha, Suk-Hoon
    Kang, Sang-Moo
    VACCINE, 2014, 32 (44) : 5824 - 5831
  • [26] Dual display hemagglutinin 1 and 5 on the surface of enveloped virus-like particles in silkworm expression system
    Goffar, Muzajjad Gozal
    Deo, Vipin Kumar
    Kato, Tatsuya
    Park, Enoch Y.
    PROTEIN EXPRESSION AND PURIFICATION, 2022, 197
  • [27] Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus
    Kang, Hae-Ji
    Chu, Ki-Back
    Yoon, Keon-Woong
    Eom, Gi-Deok
    Mao, Jie
    Quan, Fu-Shi
    BIOMEDICINES, 2022, 10 (07)
  • [28] The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza
    D'Aoust, Marc-Andre
    Couture, Manon M. -J.
    Charland, Nathalie
    Trepanier, Sonia
    Landry, Nathalie
    Ors, Frederic
    Vezina, Louis-P.
    PLANT BIOTECHNOLOGY JOURNAL, 2010, 8 (05) : 607 - 619
  • [29] Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
    Olukitibi, Titus Abiola
    Ao, Zhujun
    Azizi, Hiva
    Mahmoudi, Mona
    Coombs, Kevin
    Kobasa, Darwyn
    Kobinger, Gary
    Yao, Xiaojian
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [30] In vitro anti-viral activity of serum from mice immunized with liposomes containing the M2 ectodomain (M2e) of the influenza virus
    Ernst, W.
    Munoz, M.
    Kim, H.
    Fujii, G.
    Adler-Moore, J.
    Mothe, B.
    VACCINE, 2008,